What it does / how it works
A tetrapeptide that sticks to cardiolipin on the inner mitochondrial membrane and is studied to restore electron-transport efficiency. Some myopathy trials used 40 mg daily.
| Class | Mitochondria-targeted tetrapeptide |
| Typical vial | 10 or 50 mg |
| Reconstitution | 1–2 mL BAC per 10 mg |
| Storage after mix | 2–8°C, use within 28 days |
Protocol
| Goal | Dose | How often | How long | Route |
| Weeks 1-8 research vial | 5-10 mg | Once daily | 4-8 weeks | SubQ |
| Trial-style only | 40 mg | Once daily | 12-24 weeks in some programmes | SubQ |
| Off | None | Stop | Reassess at week 8 | – |
Watch: A 10 mg vial is a fraction of a 40 mg trial day.